InVivo Therapeutics Holdings C's ticker is NVIV and the CUSIP is 46186M100. A total of 2 filers reported holding InVivo Therapeutics Holdings C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $231,000 | -16.6% | 32,100 | 0.0% | 0.04% | -22.4% |
| Q3 2015 | $277,000 | -46.5% | 32,100 | 0.0% | 0.05% | -41.0% |
| Q2 2015 | $518,000 | +34.2% | 32,100 | -75.3% | 0.08% | +33.9% |
| Q1 2015 | $386,000 | +124.4% | 130,000 | 0.0% | 0.06% | +121.4% |
| Q4 2014 | $172,000 | +138.9% | 130,000 | 0.0% | 0.03% | +133.3% |
| Q3 2014 | $72,000 | -46.7% | 130,000 | 0.0% | 0.01% | -47.8% |
| Q2 2014 | $135,000 | -41.0% | 130,000 | 0.0% | 0.02% | -43.9% |
| Q1 2014 | $229,000 | -23.2% | 130,000 | 0.0% | 0.04% | -25.5% |
| Q4 2013 | $298,000 | +60.2% | 130,000 | 0.0% | 0.06% | +48.6% |
| Q3 2013 | $186,000 | -71.9% | 130,000 | -18.8% | 0.04% | -72.8% |
| Q2 2013 | $661,000 | – | 160,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HYMAN CHARLES D | 130,000 | $135,000 | 0.02% |
| Indiana Trust & Investment Management CO | 37,000 | $38,000 | 0.02% |